## Core Concept
The preservation of blood for transfusions requires a solution that prevents clotting, maintains cell viability, and provides nutrients. This involves understanding the role of anticoagulants and preservatives in blood banking.

## Why the Correct Answer is Right
The correct answer, **Citrate**, is used in the form of trisodium citrate or citric acid in combination with dextrose in solutions like CPDA (Citrate Phosphate Dextrose Adenine) or CPD (Citrate Phosphate Dextrose). Citrate acts as an anticoagulant by chelating calcium ions, which are essential for the coagulation cascade. This prevents blood clotting in the stored blood. Dextrose provides a source of glucose for cellular metabolism, helping to maintain the viability of red blood cells during storage.

## Why Each Wrong Option is Incorrect
- **Option A:** While certain solutions may contain dextrose for energy, dextrose alone does not prevent clotting or adequately preserve blood cells.
- **Option B:** Heparin is an anticoagulant used to prevent clotting in vivo and in certain medical devices, but it's not commonly used for long-term preservation of blood for transfusions due to its inability to provide nutrients to cells and its potential to cause thrombocytopenia.
- **Option C:** EDTA (Ethylene Diamine Tetraacetic Acid) is used as an anticoagulant in vitro, primarily in laboratory settings for blood collection tubes. However, it's not suitable for blood transfusions because it doesn't provide nutrients for cell survival.

## Clinical Pearl / High-Yield Fact
A key point to remember is that CPDA-1 (Citrate Phosphate Dextrose Adenine-1) solution is commonly used for preserving whole blood or red blood cells for up to 35 days. The addition of adenine in these solutions significantly improves the recovery of red blood cells after storage.

## Correct Answer: C. Citrate